David A Schoenfeld (David Schoenfeld)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 16

Top Topics

Brain Metastases

Immune Response

Renal Cell Carcinoma

Top Venues

Journal for immunotherapy of cancer

Cancer immunology, immunotherapy : CII

JCO precision oncology

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Oscar Perales, Lucia B Jilaveanu, Adebowale J Adeniran, David G Su, Michael E Hurwitz, David A Braun, Harriet M Kluger, David A Schoenfeld
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3. Cancer immunology, immunotherapy : CII 73 (10) (2024)
David G Su, David A Schoenfeld, Wael Ibrahim, Raysa Cabrejo, Dijana Djureinovic, Raymond Baumann, David L Rimm, Sajid A Khan, Ruth Halaban, Harriet M Kluger, Kelly Olino, Anjela Galan, James Clune
Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma. Journal for immunotherapy of cancer 12 (3) (2024)
Oscar Perales, Lucia B Jilaveanu, Adebowale J Adeniran, David G Su, Michael E Hurwitz, David A Braun, Harriet M Kluger, David A Schoenfeld
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3. Cancer immunology, immunotherapy : CII 73 (10) (2024)
David G Su, David A Schoenfeld, Wael Ibrahim, Raysa Cabrejo, Dijana Djureinovic, Raymond Baumann, David L Rimm, Sajid A Khan, Ruth Halaban, Harriet M Kluger, Kelly Olino, Anjela Galan, James Clune
Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma. Journal for immunotherapy of cancer 12 (3) (2024)
Oscar Perales, Lucia B Jilaveanu, Adebowale J Adeniran, David G Su, Michael E Hurwitz, David A Braun, Harriet M Kluger, David A Schoenfeld
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3. Cancer immunology, immunotherapy : CII 73 (10) (2024)
David G Su, Dijana Djureinovic, David A Schoenfeld, Bernadette Marquez-Nostra, Kelly Olino, Lucia Jilaveanu, Harriet M Kluger
Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma. JCO precision oncology 8 (2024)
David G Su, David A Schoenfeld, Wael Ibrahim, Raysa Cabrejo, Dijana Djureinovic, Raymond Baumann, David L Rimm, Sajid A Khan, Ruth Halaban, Harriet M Kluger, Kelly Olino, Anjela Galan, James Clune
Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma. Journal for immunotherapy of cancer 12 (3) (2024)
Oscar Perales, Lucia B Jilaveanu, Adebowale J Adeniran, David G Su, Michael E Hurwitz, David A Braun, Harriet M Kluger, David A Schoenfeld
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3. Cancer immunology, immunotherapy : CII 73 (10) (2024)
David G Su, Dijana Djureinovic, David A Schoenfeld, Bernadette Marquez-Nostra, Kelly Olino, Lucia Jilaveanu, Harriet M Kluger
Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma. JCO precision oncology 8 (2024)
David G Su, David A Schoenfeld, Wael Ibrahim, Raysa Cabrejo, Dijana Djureinovic, Raymond Baumann, David L Rimm, Sajid A Khan, Ruth Halaban, Harriet M Kluger, Kelly Olino, Anjela Galan, James Clune
Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma. Journal for immunotherapy of cancer 12 (3) (2024)
David G Su, Dijana Djureinovic, David A Schoenfeld, Bernadette Marquez-Nostra, Kelly Olino, Lucia Jilaveanu, Harriet M Kluger
Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma. JCO precision oncology 8 (2024)
David G Su, David A Schoenfeld, Wael Ibrahim, Raysa Cabrejo, Dijana Djureinovic, Raymond Baumann, David L Rimm, Sajid A Khan, Ruth Halaban, Harriet M Kluger, Kelly Olino, Anjela Galan, James Clune
Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma. Journal for immunotherapy of cancer 12 (3) (2024)
David G Su, David A Schoenfeld, Wael Ibrahim, Raysa Cabrejo, Dijana Djureinovic, Raymond Baumann, David L Rimm, Sajid A Khan, Ruth Halaban, Harriet M Kluger, Kelly Olino, Anjela Galan, James Clune
Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma. Journal for immunotherapy of cancer 12 (3) (2024)
Lilach Aizenbud, David A Schoenfeld, Jasmine I Caulfield, Jacqueline E Mann, Matthew R Austin, Ana Luisa Perdigoto, Kevan C Herold, Harriet M Kluger
Response to " NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng. Journal for immunotherapy of cancer 11 (6) (2023)
David A Schoenfeld, Myrto K Moutafi, Sandra Martinez, Dijana Djureinovic, Ross D Merkin, Adebowale Adeniran, David A Braun, Sabina Signoretti, Toni K Choueiri, Fabio Parisi, Michael Hurwitz, David L Rimm, Wei Wei, Lucia Jilaveanu, Harriet M Kluger
Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases. Journal for immunotherapy of cancer 11 (8) (2023)
David A Schoenfeld, Royce Zhou, Sakellarios Zairis, William Su, Nicole Steinbach, Deepti Mathur, Ankita Bansal, Alexis L Zachem, Bertilia Tavarez, Dan Hasson, Emily Bernstein, Raul Rabadan, Ramon E Parsons
Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma. Molecular cancer research : MCR 20 (8) (2022)